engages in the discovery and development of pharmaceutical products to improve human health.
It is developing Prestara (prasterone), an investigational drug for women with systemic lupus erythematosus.
The company also pursues drug discovery of novel antiviral compounds for treatment of hepatitis C virus infections and advances preclinical development of compounds in this program.
Genelabs Technologies has strategic collaborations with Watson Pharmaceuticals, Inc.
and Tanabe Seiyaku Co.
, Ltd.
for the development and commercialization of its investigational new drug.
The company was incorporated in California in 1985 and is headquartered in Redwood City, California.
